Berto Acquisition Corp.

What they do

Berto Acquisition Corp. was incorporated on July 15, 2024 as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company states it has neither engaged in any operations nor generated any revenue to date and is a shell company under the Exchange Act. It has not yet identified or completed an initial business combination.

Revenue drivers

• Trust account interest — The $300.15 million held in a U.S. trust account may generate interest, but such interest can generally only be released to the company to pay taxes and up to $100,000 for dissolution expenses.
• Sponsor private placement warrants — Simultaneously with the IPO, the company sold 3,500,000 sponsor private placement warrants to the Sponsor at $1.00 per warrant, generating $3.5 million in gross proceeds.
• Underwriter private placement warrants — Simultaneously with the IPO, the company issued 3,750,000 underwriter private placement warrants to designees of the Representatives.

Recent performance

For full-year 2025, the company reported net income of $7.9 million and diluted EPS of $0.29, while operating cash flow was negative $1.3 million. At June 30, 2026, total assets were $314.4 million, including $146,740 of cash and equivalents, total liabilities were $14.1 million, and shareholders' equity was negative $13.8 million.

Strategy

The company intends to identify and consummate an initial business combination, with a focus on opportunities in AI as well as wellness, longevity and aesthetics areas. It states that its articles prohibit it from effecting a business combination solely with another blank check company or similar company with nominal operations. It raised its IPO proceeds into a trust account with Continental Stock Transfer & Trust Company and is permitted to hold those funds in cash, demand deposits at a large U.S. bank, or short-term U.S. government securities or qualifying money market funds. The company also disclosed that its officers and directors may have conflicts of interest.

Risks

• Ability to complete a business combination — As a blank check company with no operations, the company may be unable to identify or complete an initial business combination within the required timeframe, which could force liquidation.
• Public shareholders may not get a vote — The company may choose not to hold a shareholder vote on its initial business combination, and even if it does, holders of founder shares will participate, so a combination may be completed despite majority public shareholder opposition.
• Shareholder equity deficit — At June 30, 2026, total liabilities of $14.1 million exceeded total assets net of equity, producing shareholders' equity of negative $13.8 million.
• Liquidity and operating cash burn — The company reported negative operating cash flow of $1.3 million in 2025, and its unrestricted cash and equivalents were only $146,740 at June 30, 2026.

Outlook

Management indicates the company continues to search for an initial business combination, with particular focus on AI, wellness, longevity and aesthetics opportunities. The funds held in the trust account will not be released until the completion of an initial business combination, other than interest for taxes and up to $100,000 for dissolution expenses. The company faces a deadline to consummate a combination or distribute trust account proceeds.